Article preview reprinted from Medtech Insight - February 2010
Growth in the hemodynamic monitoring market is being fueled by several factors, including the aging population and the increasing demand for less invasive and noninvasive technologies for measuring global parameters of oxygen delivery. While barriers to entry are high in the hemodynamic monitoring business, the prospect for future growth is significant. Read more...
Recent Trends in Hemodynamic Monitoring
Article preview reprinted from Medtech Insight - February 2010
In critical care, the goal of hemodynamic monitoring is to provide data that guides treatment and prevents morbidity and mortality of critically ill patients. Clinicians use hemodynamic monitoring data to optimize the balance between tissue oxygen supply and demand and effectively combat global tissue hypoxia, shock, and multiorgan failure in critically ill patients.
Market OutlookWithin the market for hemodynamic monitoring products, there are two main segments: pulmonary artery catheters (PACs) and cardiac output (CO) monitoring systems, which include minimally invasive and noninvasive technologies. Over the past 10 years, the market for hemodynamic monitoring products has evolved, and growth in this market is being fueled by several factors, not the least of which is an aging population with an increasing number of cardiac disorders and other conditions that could benefit from hemodynamic monitoring. Growth is also being driven by the demand for less invasive and noninvasive technologies that measure CO, stroke volume, and other global parameters of oxygen delivery. Current technologies available for hemodynamic monitoring include products based on thermodilution, dye dilution, lithium dilution, those using the Fick principle, thoracic electrical bioimpedance, esophageal Doppler monitoring, pulse contour methods, ultrasonic CO monitoring, and transesophageal echocardiography. These technologies are increasingly being used in place of the more invasive PAC.
The market for hemodynamic monitoring will also be driven by the increasing number of clinicians who can initiate and place these monitoring technologies. Previously, only a physician could initiate CO monitoring, as PAC catheters must be inserted by a physician. But with the advent of less invasive and noninvasive devices—which can be used by any nurse, physician assistant, respiratory therapist, cardiovascular technologist, or anesthesia technician familiar with basic invasive pressure monitoring—the base of clinicians that can initiate CO monitoring has increased exponentially.
In 2009, hospital-based sales of less invasive hemodynamic monitoring products was well over $120 million worldwide, according to Edwards Lifesciences Corp., an established leader in the hemodynamic monitoring market. Clinicians in the US have been slower to adopt the less invasive and noninvasive hemodynamic monitoring products than those in Europe and other countries; however, US sales of these technologies have been steadily growing and are projected to reach $69.0 million by 2012. And while the barriers to entry are high for this business, the prospect for future growth is significant, with the worldwide potential for hemodynamic monitoring estimated by Edwards at $540 million.
Purchase this article online as a PDF and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satis faction Guaranteed. Subscribe to Medtech Insight.
Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Availible for purchase now!
Companies mentioned in this article:
CAS Medical Systems Inc.
Dexcom Inc.
Draegerwerk AG
Draeger Medical AG
Draeger Medical Inc.
Edwards Lifesciences Corp.
General Electric Co.
GE Healthcare
Pulsion Medical Systems AG
Royal Philips Electronics NV
Philips Medical Systems Inc.
SonoSite Inc.
CardioDynamics International Corp.
About Medtech Insight
Medtech Insight newsletter provides insights into the technology and market developments (devices, instrumentation, biomaterials, gene therapy, tissue engineering, etc.) impacting a wide range of surgical and non-surgical clinical practices.
Comments